Journals
Monday February 20, 2017

Volume 54 Number 4

October - December 2016 Issue

 

 

C O N T E N T S

 

Editorial

On Being a Doctor, Physician, and Teacher

Margarita T. Cayco, M.D.

 

Legal Prescription

Prescribing Dangerous Drugs and the Law (Part 3)

Atty. Rodel V. Capule M.D.

 

Original Papers

A Comparison Between Dialysis Versus Conservative Management as Modes of Treatment in the Management of Elderly Patients with End-Stage Renal Disease: A Systematic Review

Kristine Mae Vega-Alava, M.D. and Vimar A. Luz, M.D.

 

Complications of Ultrasound-Guided Percutaneous Renal Biopsy at the National Kidney and Transplant Institute: A Radiologic Perspective

Ma. Regina S. Morabe-Dy, M.D., Ferdinand L. Morabe, M.D. and Luis V. Limchiu, Jr., M.D.

 

The Incidence of Mycobacterium Other than Tuberculosis Isolated in Specimens Suspected of Tuberculosis in a Tertiary Hospital in the Philippines: A Retrospective Study

Rosario Pinkie V. Siapno, M.D., Caroline Bernadette O. King Kay, M.D. and Julie Christie G. Visperas M.D.

 

Case Reports

A Rare Case of an Intracardiac Hemangioma Causing Significant Right Ventricular Outflow Tract Obstruction

Lauro L. Abrahan, IV, M.D.,  Stephanie Martha O. Obillos, M.D., Jaime Alfonso M. Aherrera, M.D., Jezreel Taquiso, M.D., Jose Donato Magno, M.D., Celia Catherine Uy-Agbayani, M.D., Nelson S. Abelardo, M.D., Angelique Bea Uy, Rich Ericson King and Kathleen Rose Descallar-Mata, M.D.

 

An Extremely Rare Case of Primary Aorto-enteric Fistula in a Filipino Patient

John Daniel A. Ramos, M.D., Ma. Teresa Abola, M.D., and Patrick Louie Maglaya, M.D.

 

Dysgenesis of the Corpus Callosum Presenting as First-onset Seizures in an Apparently Normal 32-year-old

Alvin Christian C. Borbon, MD,  Mitzi Marie Chua, M.D., and Zerlyn Leonardo, M.D.

 

Rituximab for Refractory Anemia and Thrombocytopenia in a Patient with Systemic Lupus Erythematosus

Rhona L. Recto, M.D., Armin Masbang, M.D., and Charito C. Cruz-Bermudez, M.D.

 

Clinical Trial

Effectiveness, Safety and Tolerability of Vildagliptin and Vildagliptin+Metformin in Real-world Setting in the Philippines—Results from the GUARD Study

Reynaldo Rosales, M.D., Francis Domingo, M.D., and Joselito Javier, M.D.